HomeGrants › RFA-CA-27-012

Open

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Federal funding opportunity RFA-CA-27-012 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes September 25, 2026

Posted
June 4, 2026
Closes
September 25, 2026
Award ceiling
$1,300,000
Program funding
$6,800,000
Expected awards
4
Cost sharing
No
Instrument
Cooperative Agreement
Assistance listing
93.396
Category
Health
Archives
November 24, 2026

Program funding history

Awards made under Assistance Listing 93.396 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$872.6M
FY2025 obligated
$914.3M
FY2026 (to date) obligated
$446.1M
Awards in window
3,298

Top recipients: The Univeristy of Texas M.d. Anderson Cancer Center, The Trustees of Columbia University in the City of New York, Sloan-kettering Institute for Cancer Research, Trustees of the University of Pennsylvania, the, Weill Medical College of Cornell University

Source: USAspending.gov · refreshed July 2026

Synopsis

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source.

View on Grants.gov

Agency contact: National Institutes of Health · NCIMetNet@mail.nih.gov · 301-402-2541

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.

The free edition carries one clearly labeled sponsor slot. No spam, ever. Privacy

Similar grants

Never miss a funding deadline again

Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.

Get funding alerts